225 related articles for article (PubMed ID: 29944835)
1. Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process.
Dickens D; Rädisch S; Chiduza GN; Giannoudis A; Cross MJ; Malik H; Schaeffeler E; Sison-Young RL; Wilkinson EL; Goldring CE; Schwab M; Pirmohamed M; Nies AT
Mol Pharm; 2018 Aug; 15(8):3557-3572. PubMed ID: 29944835
[TBL] [Abstract][Full Text] [Related]
2. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
4. Effects of typical and atypical antipsychotics on human glycine transporters.
Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
[TBL] [Abstract][Full Text] [Related]
5. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the evidence of clozapine's anti-aggressive effects.
Frogley C; Taylor D; Dickens G; Picchioni M
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
[TBL] [Abstract][Full Text] [Related]
7. Classics in chemical neuroscience: clozapine.
Wenthur CJ; Lindsley CW
ACS Chem Neurosci; 2013 Jul; 4(7):1018-25. PubMed ID: 24047509
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.
Karmacharya R; Lynn SK; Demarco S; Ortiz A; Wang X; Lundy MY; Xie Z; Cohen BM; Miller GM; Buttner EA
Brain Res; 2011 Jun; 1393():91-9. PubMed ID: 21529784
[TBL] [Abstract][Full Text] [Related]
9. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
10. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
11. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
Ewald HL; Mors NP; Rosenberg R
Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
[TBL] [Abstract][Full Text] [Related]
12. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
13. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine is a substrate for OCT1 in brain endothelial cells.
Dickens D; Owen A; Alfirevic A; Giannoudis A; Davies A; Weksler B; Romero IA; Couraud PO; Pirmohamed M
Biochem Pharmacol; 2012 Mar; 83(6):805-14. PubMed ID: 22227272
[TBL] [Abstract][Full Text] [Related]
15. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
16. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
[TBL] [Abstract][Full Text] [Related]
17. Clozapine as a Model for Antipsychotic Development.
Nucifora FC; Mihaljevic M; Lee BJ; Sawa A
Neurotherapeutics; 2017 Jul; 14(3):750-761. PubMed ID: 28653280
[TBL] [Abstract][Full Text] [Related]
18. Unique Effects of Clozapine: A Pharmacological Perspective.
Khokhar JY; Henricks AM; Sullivan EDK; Green AI
Adv Pharmacol; 2018; 82():137-162. PubMed ID: 29413518
[TBL] [Abstract][Full Text] [Related]
19. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.
Arranz MJ; Collier DA; Munro J; Sham P; Kirov G; Sodhi M; Roberts G; Price J; Kerwin RW
Neurosci Lett; 1996 Oct; 217(2-3):177-8. PubMed ID: 8916101
[TBL] [Abstract][Full Text] [Related]
20. Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.
Bexten M; Oswald S; Grube M; Jia J; Graf T; Zimmermann U; Rodewald K; Zolk O; Schwantes U; Siegmund W; Keiser M
Mol Pharm; 2015 Jan; 12(1):171-8. PubMed ID: 25466967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
